Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996;19(3):181-6.
doi: 10.1007/BF00744210.

Multidrug resistance evaluation by confocal microscopy in primary urothelial cancer explant colonies

Affiliations

Multidrug resistance evaluation by confocal microscopy in primary urothelial cancer explant colonies

A J Cooper et al. Cytotechnology. 1996.

Abstract

Assessing functional multidrug resistance (MDR) status in clinical biopsy material using drug autofluorescence has potential applications to clinical management. The small size of many cystoscopy specimens has led us to develop, as an alternative to flow cytometry, a protocol for studying epirubicin accumulation in adherent colonies of primary bladder cancer cells viewed live and in situ by confocal microscopy. The limitations to quantitation inherent in this technique are compensated for by preservation of cellular organisation and the elimination of non-malignant cells. Biopsy material is disaggregated and explanted into culture-grade petri dishes. After incubation for three to seven days plaques of epithelial cells have developed. Classical patterns of sensitive and resistant drug distribution are observed. Cells of the rolled edges of the colony accumulate more drug than those of the inner epithelial monolayer. Some central areas of larger colonies give the appearance of drug arrested at the intercellular junctions to give a fenestrated pattern. These observations contribute to the understanding of mechanisms in MDR as well as forming the basis for a clinical urological MDR evaluation protocol.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biochem Pharmacol. 1989 Dec 15;38(24):4467-75 - PubMed
    1. Br J Cancer. 1989 Sep;60(3):282-7 - PubMed
    1. J Urol. 1990 Jul;144(1):169-71 - PubMed
    1. Nat Med. 1995 Jun;1(6):578-82 - PubMed
    1. Cancer Res. 1993 Feb 15;53(4):747-54 - PubMed

Publication types

MeSH terms

LinkOut - more resources